<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000538636">
  <TermName>Aurora kinase inhibitor AT9283</TermName>
  <TermPronunciation>(uh-ROR-uh KY-nays in-HIH-bih-ter...)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>A substance being studied in the treatment of some types of cancer. It blocks enzymes (Aurora kinases) involved in cell division and may kill cancer cells. Aurora kinase inhibitor AT9283 is a type of serine/threonine protein kinase inhibitor. Also called AT9283.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000718027" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Aurora kinase inhibitor AT9283&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000718028" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;inhibidor de la cinasa Aurora AT9283&quot;" language="es" id="_4"/>
  <SpanishTermName>inhibidor de la cinasa Aurora AT9283</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Sustancia en estudio para el tratamiento de algunos tipos de cáncer. Bloquea las enzimas (cinasas Aurora) que participan en la división celular y podría destruir las células cancerosas. El inhibidor de la cinasa Aurora AT9283 es un tipo de inhibidor de la proteína cinasa de serina/treonina. También se llama AT9283.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2007-10-04</DateFirstPublished>
</GlossaryTerm>
